Tokai Pharmaceuticals' Series E Round

Tokai Pharmaceuticals raised a round of funding on May 15, 2013.

Tokai Pharmaceuticals (NASDAQ:TKAI) is a biopharmaceutical company focused on developing and commercializing therapies for prostate cancer and other hormonally driven diseases. The company's lead drug…

Articles about Tokai Pharmaceuticals' Series E Round: